Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fuji
Daiichi Sankyo
Express Scripts
Merck
US Army
Farmers Insurance
Johnson and Johnson
US Department of Justice

Generated: April 25, 2018

DrugPatentWatch Database Preview

OSELTAMIVIR PHOSPHATE Drug Profile

« Back to Dashboard

Which patents cover Oseltamivir Phosphate, and what generic alternatives are available?

Oseltamivir Phosphate is a drug marketed by Amneal Pharms, Hetero Labs Ltd Iii, Lupin Atlantis, Macleods Pharms Ltd, Natco Pharma Ltd, Nesher Pharms, and Alvogen Pine Brook. and is included in nine NDAs.

The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Drug patent expirations by year for OSELTAMIVIR PHOSPHATE
Medical Subject Heading (MeSH) Categories for OSELTAMIVIR PHOSPHATE
Synonyms for OSELTAMIVIR PHOSPHATE
(3R-(3alpha,4beta,5alpha)-Ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)
(3R-(3alpha,4beta,5alpha))-Ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)
(3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid ethyl ester phosphate
(3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid ethyl ester phosphoric acid salt
(3R,5S)-ethyl4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha)-, phosphate (1:1)
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, phosphate
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, phosphate (1:1)
204255-11-8
255O118
4A3O49NGEZ
AB0011433
ABP000749
AC-25911
AC1L2U9Q
ACT03369
AK143302
AKOS015896056
BC216470
BCP9001033
BCPP000138
C08093
C16H28N2O4.H3O4P
C16H28N2O4.H3PO4
CCG-230250
CHEBI:7799
CHEMBL1200340
CS-0871
D00900
DTXSID0044230
Ebilfumin (TN)
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate, phosphate (1:1)
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate phosphate
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate; phosphoric acid
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate;phosphoric acid
ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; phosphoric acid
GS-4104/002
GS4104
HY-17016
I06-1861
J-013302
J-523838
J10429
KS-1184
LS-173828
MCULE-3939535663
MFCD08059548
MLS006011559
MolPort-005-938-626
OR240134
Oseltamir Phosphate
Oseltamivir (phosphate)
Oseltamivir phosphate (impurity B free), European Pharmacopoeia (EP) Reference Standard
Oseltamivir phosphate (JAN/USAN)
Oseltamivir phosphate [USAN:USP]
Oseltamivir Phosphate [USAN]
Oseltamivir phosphate, >=98% (HPLC)
Oseltamivir Phosphate, pharmaceutical secondary standard; traceable to USP, PhEur
Oseltamivir phosphate, United States Pharmacopeia (USP) Reference Standard
Oseltamivirphosphate
Osteltamivir phosphate
PGZUMBJQJWIWGJ-ONAKXNSWSA-N
phosphoric acid ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
RL02533
Ro 64-0796
Ro 64-0796/002
Ro-64-0796-002
Ro-64-0796/002
Ro-640796002
s2597
SCHEMBL8730
SMR004703323
SR-05000001499
SR-05000001499-2
ST24048849
Tamiflu
Tamiflu (TN)
UNII-4A3O49NGEZ
W-5362
Z1550675456

US Patents and Regulatory Information for OSELTAMIVIR PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 209093-001 May 17, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Nesher Pharms OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 208578-003 Feb 24, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lupin Atlantis OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 208348-001 Jan 9, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hetero Labs Ltd Iii OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 209438-001 Feb 23, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Merck
Deloitte
Johnson and Johnson
Moodys
Federal Trade Commission
Cipla
Cerilliant
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.